ArticleHeart rhythm O22025
Impact of atrial functional substrate in patients with atrial fibrillation: The potential utility of decremental evoked potential mapping in the atrium.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Decremental evoked potential (DEEP) is one of the functional substrates mainly used in the field of ventricular arrhythmias, which is suggested to be a critical target of reentrant ventricular tachycardia. Objective: The purpose of this study is to investigate the characteristics of patients with atrial functional substrates expressed by DEEP and their clinical significance. Methods: Patients presenting for atrial fibrillation (AF) ablation from April 2023 to March 2024 at Tottori University Hospital were analyzed. After cryoballoon pulmonary vein isolation, DEEP was evaluated at the left atrial roof and posterior wall by extrastimulus pacing maneuvers. To verify the clinical significance of atrial DEEP, the relationship between atrial DEEP and various clinical valuables including the pericardial fat volume and clinical outcomes was assessed. Results: A total of 102 patients were included and 45% had persistent AF. Fifty-three percent of patients exhibited DEEP properties. DEEP was more prevalent in patients with persistent AF (61% vs 39%, Conclusion: This study demonstrated a correlation between atrial DEEP and longer duration of AF, higher brain natriuretic peptide levels, greater pericardial fat volume, and more early AF recurrence, suggesting that DEEP reflects a certain aspect of atrial electrophysiological remodeling and is a potential ablation target for AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.